Grepafloxacin hydrochloride was an oral broad-spectrum fluoroquinolone
antibacterial agent used to treat bacterial infections. Grepafloxacin was
Description, Grepafloxacin is an oral broad-spectrum quinoline antibacterial
agent used to treat bacterial infections. Grepafloxacin was withdrawn in the
Dec 8, 2004 ... RAXAR Tablets contain grepafloxacin hydrochloride RAXAR (grepafloxacin) is a
broad-spectrum fluoroquinolone antimicrobial agent for oral ...
Dec 8, 2004 ... Learn about indications, dosage and how it is supplied for the drug Raxar (
Withdrawal of Product: RAXAR( (grepafloxacin HCl) 600 mg Tablets, 400 mg
Tablets, and 200 mg Tablets. Glaxo Wellcome has voluntarily withdrawn all ...
Grepafloxacin (OPC-17116) is a new once-daily fluoroquinolone antimicrobial
agent which appears to have high tissue penetration and the wide spectrum of ...
OBJECTIVE: To compare the efficacy and safety of a 7-day course of treatment
with oral grepafloxacin, 400 mg once daily, and oral doxycycline, 100 mg twice ...
Glaxo Wellcome has announced that it is voluntarily withdrawing the oral
fluoroquinolone antibiotic, grepafloxacin, with immediate effect. Since marketing
Raxar (grepafloxacin): Treatment for chronic bronchitis. New approved drug
details including side effects, uses and general information.
Dec 29, 2014 ... A comparison of the structure of ciprofloxacin and grepafloxacin shows that the
two compounds are similar, with two exceptions: grepafloxacin ...